Abacus Life (ABL) Prices $25M Notes Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Abacus Life, Inc. Prices Public Offering of $25 Million Additional 9.875% Notes Due 2028
February 12, 2024 7:30 AM ESTORLANDO, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (Abacus or the Company) (NASDAQ: ABL; ABLLL) today announced that it has priced an underwritten public offering of $25 million in aggregate principal amount of its additional 9.875% notes due 2028 (the New Notes). The New Notes will have the same terms (except with respect to issue date and the date from which interest will accrue) as, will be fully fungible with and will be treated as a single series of debt securities as, the 9.875% notes due 2028 the Company issued on November 10, 2023 in an aggregate principal amount of $35,650,000 (the Existing Notes and together with the... More



